TY - JOUR
T1 - PINE-TREE enables highly efficient genetic modification of human cell lines
AU - Frisch, Carlye
AU - Kostes, William W.
AU - Galyon, Brooke
AU - Whitman, Brycelyn
AU - Tekel, Stefan J.
AU - Standage-Beier, Kylie
AU - Srinivasan, Gayathri
AU - Wang, Xiao
AU - Brafman, David A.
N1 - Publisher Copyright: © 2023 The Authors
PY - 2023/9/12
Y1 - 2023/9/12
N2 - Prime editing technologies enable precise genome editing without the caveats of CRISPR nuclease-based methods. Nonetheless, current approaches to identify and isolate prime-edited cell populations are inefficient. Here, we established a fluorescence-based system, prime-induced nucleotide engineering using a transient reporter for editing enrichment (PINE-TREE), for real-time enrichment of prime-edited cell populations. We demonstrated the broad utility of PINE-TREE for highly efficient introduction of substitutions, insertions, and deletions at various genomic loci. Finally, we employ PINE-TREE to rapidly and efficiently generate clonal isogenic human pluripotent stem cell lines, a cell type recalcitrant to genome editing.
AB - Prime editing technologies enable precise genome editing without the caveats of CRISPR nuclease-based methods. Nonetheless, current approaches to identify and isolate prime-edited cell populations are inefficient. Here, we established a fluorescence-based system, prime-induced nucleotide engineering using a transient reporter for editing enrichment (PINE-TREE), for real-time enrichment of prime-edited cell populations. We demonstrated the broad utility of PINE-TREE for highly efficient introduction of substitutions, insertions, and deletions at various genomic loci. Finally, we employ PINE-TREE to rapidly and efficiently generate clonal isogenic human pluripotent stem cell lines, a cell type recalcitrant to genome editing.
KW - CRISPR
KW - MT: RNA/DNA
KW - genome modification
KW - human pluripotent stem cells
KW - prime editing
UR - http://www.scopus.com/inward/record.url?scp=85169031403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85169031403&partnerID=8YFLogxK
U2 - 10.1016/j.omtn.2023.07.007
DO - 10.1016/j.omtn.2023.07.007
M3 - Article
SN - 2162-2531
VL - 33
SP - 483
EP - 492
JO - Molecular Therapy - Nucleic Acids
JF - Molecular Therapy - Nucleic Acids
ER -